Lamble A, Kovach A, Shah N
Blood. 2024; 145(1):64-74.
PMID: 39046821
PMC: 11738038.
DOI: 10.1182/blood.2024024517.
Sigvardsson M
Genes Dev. 2023; 37(15-16):703-723.
PMID: 37673459
PMC: 10546977.
DOI: 10.1101/gad.349879.122.
Aldoss I, Tizro P, Bedi D, Mangan J, Clark M, Spencer D
Haematologica. 2023; 108(12):3511-3516.
PMID: 37470155
PMC: 10690902.
DOI: 10.3324/haematol.2023.283566.
Lussana F, Cavallaro G, De Simone P, Rambaldi A
Cancers (Basel). 2023; 15(4).
PMID: 36831690
PMC: 9954469.
DOI: 10.3390/cancers15041349.
Della Starza I, De Novi L, Elia L, Bellomarino V, Beldinanzi M, Soscia R
Cancers (Basel). 2023; 15(2).
PMID: 36672325
PMC: 9856386.
DOI: 10.3390/cancers15020374.
Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells.
Lamble A, Myers R, Taraseviciute A, John S, Yates B, Steinberg S
Blood Adv. 2022; 7(4):575-585.
PMID: 35482927
PMC: 9979750.
DOI: 10.1182/bloodadvances.2022007423.
An Unusual Presentation of Extramedullary Relapse Following Blinatumomab in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
Daghri S, Bendari M, Belmoufid N, Yahyaoui A, Ahnach M
Cureus. 2022; 14(3):e23262.
PMID: 35449608
PMC: 9013240.
DOI: 10.7759/cureus.23262.
Repeated Lineage Switches in an Elderly Case of Refractory B-Cell Acute Lymphoblastic Leukemia With Gene Amplification: A Case Report and Literature Review.
Takeda R, Yokoyama K, Fukuyama T, Kawamata T, Ito M, Yusa N
Front Oncol. 2022; 12:799982.
PMID: 35402256
PMC: 8983914.
DOI: 10.3389/fonc.2022.799982.
Does lineage plasticity enable escape from CAR-T cell therapy? Lessons from MLL-r leukemia.
Liao W, Kohler M, Fry T, Ernst P
Exp Hematol. 2021; 100:1-11.
PMID: 34298117
PMC: 8611617.
DOI: 10.1016/j.exphem.2021.07.002.
Blinatumomab in Pediatric Acute Lymphoblastic Leukemia-From Salvage to First Line Therapy (A Systematic Review).
Queudeville M, Ebinger M
J Clin Med. 2021; 10(12).
PMID: 34201368
PMC: 8230017.
DOI: 10.3390/jcm10122544.
LAMP-5 is an essential inflammatory-signaling regulator and novel immunotherapy target for mixed lineage leukemia-rearranged acute leukemia.
Gracia-Maldonado G, Clark J, Burwinkel M, Greenslade B, Wunderlich M, Salomonis N
Haematologica. 2021; 107(4):803-815.
PMID: 33910331
PMC: 8968879.
DOI: 10.3324/haematol.2020.257451.
Immunotherapy of Acute Lymphoblastic Leukemia and Lymphoma With T Cell-Redirected Bispecific Antibodies.
Lussana F, Gritti G, Rambaldi A
J Clin Oncol. 2021; 39(5):444-455.
PMID: 33434063
PMC: 8078487.
DOI: 10.1200/JCO.20.01564.
DUX4r, ZNF384r and PAX5-P80R mutated B-cell precursor acute lymphoblastic leukemia frequently undergo monocytic switch.
Novakova M, Zaliova M, Fiser K, Vakrmanova B, Slamova L, Musilova A
Haematologica. 2020; 106(8):2066-2075.
PMID: 32646889
PMC: 8327733.
DOI: 10.3324/haematol.2020.250423.
Personalized therapy in pediatric high-risk B-cell acute lymphoblastic leukemia.
Karol S, Pui C
Ther Adv Hematol. 2020; 11:2040620720927575.
PMID: 32537116
PMC: 7268159.
DOI: 10.1177/2040620720927575.
Lineage switch from T-cell lymphoblastic leukemia/lymphoma to acute myeloid leukemia and back to T-cell lymphoblastic leukemia/lymphoma in a patient diagnosed during pregnancy.
Aujla A, Hanmantgad M, Islam H, Shakil F, Liu D, Seiter K
Stem Cell Investig. 2019; 6:12.
PMID: 31231669
PMC: 6556683.
DOI: 10.21037/sci.2019.05.02.
Circular RNA and mRNA profiling reveal competing endogenous RNA networks during avian leukosis virus, subgroup J-induced tumorigenesis in chickens.
Qiu L, Chang G, Bi Y, Liu X, Chen G
PLoS One. 2018; 13(10):e0204931.
PMID: 30286182
PMC: 6171863.
DOI: 10.1371/journal.pone.0204931.
